Skip to main content


Should Teladoc be worried about GoodRx?

By The Motley Fool  
   September 25, 2020

On Wednesday, GoodRx went public at $33 a share. After a nice pop on its opening day, it pulled back a bit on Thursday, and as of early afternoon Friday, shares are trading hands around $49. At that price, the company is valued around $19 billion. That gives GoodRx a greater market cap than virtual healthcare specialist Teladoc Health, which is worth about $18 billion.

Full story

Get the latest on healthcare leadership in your inbox.